🔹 Revenue: $884M (Est. $862.8M) 🟢; UP +42% YoY
🔹 Adj EPS: $0.13 (Est. $0.13) 🟡
🔹 Adj EBITDA: $197M
🔹 Rule of 40 Score: 87%
Q2 Guidance:
🔹 Revenue: $134M–$138M (Est. $198.5M) 🟢
🔹 Adjusted Income from Operations: $40M–$45M
FY25 Guidance:
🔹 Revenue: $3.89B–$3.90B (Est. $3.75B) 🟢
🔹 U.S. Commercial Revenue Guidance: >$1.178B; UP +68% YoY
🔹 Adjusted Income from Operations: $1.711B–$1.723B
🔹 Adjusted Free Cash Flow: $1.6B–$1.8B
🔹 GAAP Operating Income and Net Income expected in every quarter
Q1 Segment & Regional Performance:
🔹 U.S. Revenue: $628M; UP +55% YoY, +13% QoQ
🔹 U.S. Commercial Revenue: $255M; UP +71% YoY, +19% QoQ
🔹 U.S. Government Revenue: $373M; UP +45% YoY, +9% QoQ
🔹 Total Customer Count: UP +39% YoY, +8% QoQ
🔹 Closed 139 deals ≥ $1M; 51 ≥ $5M; 31 ≥ $10M
Contract Metrics:
🔹 U.S. Commercial Total Contract Value (TCV): $810M; UP +183% YoY
🔹 U.S. Commercial Remaining Deal Value (RDV): $2.32B; UP +127% YoY, +30% QoQ
Other Metrics:
🔹 Adjusted Income from Operations: $391M; Margin 44%
🔹 GAAP Income from Operations: $176M; Margin 20%
🔹 Adjusted Free Cash Flow: $370M; Margin 42%
🔹 Cash from Operations: $310M; Margin 35%
🔹 Net Income: $214M; Margin 24%
🔹 Cash, Equivalents & U.S. Treasuries: $5.4B
CEO Andrew Dudum's Commentary:
🔸 "Our Q1 results reflect strong execution across the Hims and Hers brands, reaching 2 million subscribers and enhancing access to high-quality, personalized care. We continue to build a platform aimed at helping every American household access affordable and transparent health solutions."